Title Credit Type Event date Cost
Advances in Influenza Treatment: Optimizing Outcomes in High-Risk Influenza Patients with Chronic Cardiometabolic Conditions
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00
Virtual Symposium: The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches
    • 1.50 CDE
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.20 ANCC
    • 1.25 Participation
 Enduring $0.00
When COVID-19 Meets Interstitial Lung Disease: Implications for Acute and Long-Term Management
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Challenging the Status-Quo: Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond—Expert Debate and Discussions
    • 2.25 ACPE Pharmacy
    • 2.25 AMA PRA Category 1 Credit™
    • 2.25 ANCC
    • 2.25 Participation
 Enduring $0.00
Vaccine-Preventable Diseases in the Age of COVID-19: How Can We Keep Them at Bay?
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00
Clinical Brief: Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 CDE
    • 0.75 Participation
 Enduring $0.00
2020 CMHC Annual On Demand - Evolving Paradigms in Cardiometabolic Care: Disparities & Advancements
    • 15.00 CDE
    • 15.00 ACPE Pharmacy
    • 15.00 AMA PRA Category 1 Credit™
    • 15.00 ANCC
    • 15.00 Participation
 Enduring $0.00
Virtual Symposium: ABC Access To Care Initiative: Overcoming Disparities and Gaps in the Diagnosis and Treatment of Familial Hypercholesterolemia
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 CDE
    • 1.50 Participation
 Enduring $0.00
Virtual Symposium: Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 CDE
    • 1.00 Participation
 Enduring $0.00
Virtual Symposium - Preventing Adverse Cardiovascular and Limb Events in High-Risk Cardiometabolic Patients with Peripheral Artery Disease: Recent...
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Clinical Brief: What BMI Should Be Used for Metabolic Surgery?
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 CDE
    • 0.50 Participation
 Enduring $0.00
The Nexus of COPD, Cardiovascular Disease, and COVID-19: Key Strategies To Optimize Outcomes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Virtual Symposium - The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients: Advances and Opportunities
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Virtual Symposium - Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
CMHC Masterclass On Demand: Who Best to Stem the Cardiometabolic Tsunami
    • 6.75 CDE
    • 6.75 ACPE Pharmacy
    • 6.75 AMA PRA Category 1 Credit™
    • 6.75 ANCC
    • 6.75 Participation
 Enduring $0.00

Pages